These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11162921)

  • 21. Nucleosome positioning and transcription-associated chromatin alterations on the human estrogen-responsive pS2 promoter.
    Sewack GF; Hansen U
    J Biol Chem; 1997 Dec; 272(49):31118-29. PubMed ID: 9388265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations.
    van Agthoven T; van Agthoven TL; Dekker A; Foekens JA; Dorssers LC
    Mol Endocrinol; 1994 Nov; 8(11):1474-83. PubMed ID: 7533260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.
    Biswas DK; Averboukh L; Sheng S; Martin K; Ewaniuk DS; Jawde TF; Wang F; Pardee AB
    Mol Med; 1998 Jul; 4(7):454-67. PubMed ID: 9713824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation.
    Vendrell JA; Magnino F; Danis E; Duchesne MJ; Pinloche S; Pons M; Birnbaum D; Nguyen C; Theillet C; Cohen PA
    J Mol Endocrinol; 2004 Apr; 32(2):397-414. PubMed ID: 15072547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An estrogen-responsive element-targeted histone deacetylase enzyme has an antiestrogen activity that differs from that of hydroxytamoxifen.
    Demirpence E; Semlali A; Oliva J; Balaguer P; Badia E; Duchesne MJ; Nicolas JC; Pons M
    Cancer Res; 2002 Nov; 62(22):6519-28. PubMed ID: 12438246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
    Lau KM; LaSpina M; Long J; Ho SM
    Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V; Gougelet A; Maillard S; Renoir JM
    Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced pS2 expression.
    Zacharewski TR; Bondy KL; McDonell P; Wu ZF
    Cancer Res; 1994 May; 54(10):2707-13. PubMed ID: 8168101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
    Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
    Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional implications of antiestrogen induction of quinone reductase: inhibition of estrogen-induced deoxyribonucleic acid damage.
    Bianco NR; Perry G; Smith MA; Templeton DJ; Montano MM
    Mol Endocrinol; 2003 Jul; 17(7):1344-55. PubMed ID: 12714703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors.
    Lu D; Kiriyama Y; Lee KY; Giguère V
    Cancer Res; 2001 Sep; 61(18):6755-61. PubMed ID: 11559547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The estrogen responsive element of the pS2 gene is recognized by a methylation sensitive DNA binding protein.
    Martin V; Ribieras S; Rio MC; Dante R
    Biol Chem; 1998; 379(4-5):409-16. PubMed ID: 9628331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-culture of primary human mammary fibroblasts and MCF-7 cells as an in vitro breast cancer model.
    Heneweer M; Muusse M; Dingemans M; de Jong PC; van den Berg M; Sanderson JT
    Toxicol Sci; 2005 Feb; 83(2):257-63. PubMed ID: 15525692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a hormone-responsive promoter immediately upstream of exon 1c in the human vitamin D receptor gene.
    Byrne IM; Flanagan L; Tenniswood MP; Welsh J
    Endocrinology; 2000 Aug; 141(8):2829-36. PubMed ID: 10919269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of antiestrogens on pS2 and cathepsin D mRNA induction in MCF-7 breast cancer cells.
    Rajah TT; Dunn ST; Pento JT
    Anticancer Res; 1996; 16(2):837-42. PubMed ID: 8687138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct effects of gonadotropin-releasing hormone analogs and 4-hydroxytamoxifen on pS2 mRNA expression with respect to cell proliferation in MCF-7 breast cancer cells.
    Neri C; Colomb E; Roux-Dosseto M; Martin PM
    Anticancer Res; 1991; 11(1):411-5. PubMed ID: 1826824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cooperation between the human estrogen receptor (ER) and MCF-7 cell-specific transcription factors elicits high activity of an estrogen-inducible enhancer from the trout ER gene promoter.
    Lazennec G; Kern L; Salbert G; Saligaut D; Valotaire Y
    Mol Endocrinol; 1996 Sep; 10(9):1116-26. PubMed ID: 8885246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and -independent breast cancer cell lines.
    Giamarchi C; Solanas M; Chailleux C; Augereau P; Vignon F; Rochefort H; Richard-Foy H
    Oncogene; 1999 Jan; 18(2):533-41. PubMed ID: 9927210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human prolactin gene promoter regulation by estrogen: convergence with tumor necrosis factor-alpha signaling.
    Adamson AD; Friedrichsen S; Semprini S; Harper CV; Mullins JJ; White MR; Davis JR
    Endocrinology; 2008 Feb; 149(2):687-94. PubMed ID: 18006630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
    Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
    J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.